Sale of Securities

Cadrenal Therapeutics, Inc. Filed 2025-10-06 Acc 0001950047-25-007779

Documents 1

2025-10-09 144 Sale of Securities
2025-10-09 144 Sale of Securities
2025-10-07 4 Chief Financial Officer sold 107 shares at $13.99 ($1,497)
2025-10-06 144 Sale of Securities
2025-10-03 4 CEO and Chairman sold 500 shares at $14.13 ($7,065)
2025-10-02 144 Sale of Securities
2025-10-01 4 Chief Financial Officer sold 1,800 shares at an average $13.99 ($25,183)

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…